Thirteen years after cervical cancer, I’ve found strength in healing, grief in silence, and hope in sharing the quiet truths ...

Sanofi and Regeneron’s checkpoint inhibitor Libtayo has become the first immunotherapy to improve survival when used as a second-line therapy in cervical cancer, setting up regulatory filings ...

The latest news on cancer, health, medicines, cancer treatments, cancer research, cancer studies and types of cancer.

Objectives Women with severe mental illness (SMI) face barriers to cervical cancer screening, leading to lower participation and poorer outcomes. This research aimed to develop and test an ...

Want to feel more hopeful and do more good? Read positive news from the number one source for real good news — not just 'feel good' news.